Cargando…
Antidiabetic drug metformin suppresses tumorigenesis through inhibition of mevalonate pathway enzyme HMGCS1
Metformin, an antidiabetic drug, shows some potent antitumor effects. However, the molecular mechanism of metformin in tumor suppression has not been clarified. Here, we provided evidence using in vitro and in vivo data that metformin inhibited mevalonate pathway by downregulation of 3-hydroxy-3-met...
Autores principales: | Chen, Yiyan, Li, Min, Yang, Yanying, Lu, Yan, Li, Xiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723917/ https://www.ncbi.nlm.nih.gov/pubmed/36356901 http://dx.doi.org/10.1016/j.jbc.2022.102678 |
Ejemplares similares
-
Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression
por: Wang, I-Han, et al.
Publicado: (2020) -
Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR
por: Ashida, Shingo, et al.
Publicado: (2017) -
The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer
por: Walsh, Claire A., et al.
Publicado: (2020) -
Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer
por: Seo, Yoojeong, et al.
Publicado: (2020) -
Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells
por: Kim, Ji Tae, et al.
Publicado: (2019)